TR200102540T2 - Heterosiklik bileşimler, ara ürünleri ve elastaz inhibitörleri. - Google Patents

Heterosiklik bileşimler, ara ürünleri ve elastaz inhibitörleri.

Info

Publication number
TR200102540T2
TR200102540T2 TR2001/02540T TR200102540T TR200102540T2 TR 200102540 T2 TR200102540 T2 TR 200102540T2 TR 2001/02540 T TR2001/02540 T TR 2001/02540T TR 200102540 T TR200102540 T TR 200102540T TR 200102540 T2 TR200102540 T2 TR 200102540T2
Authority
TR
Turkey
Prior art keywords
group
different
same
intermediates
elastase inhibitors
Prior art date
Application number
TR2001/02540T
Other languages
English (en)
Turkish (tr)
Inventor
Sato Fuminori
Inoue Yasunao
Omodani Tomoki
Shiratake Ryotaro
Honda Seiji
Komiya Masanobu
Takemura Tadashi
Original Assignee
Dainippon Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co., Ltd. filed Critical Dainippon Pharmaceutical Co., Ltd.
Publication of TR200102540T2 publication Critical patent/TR200102540T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
TR2001/02540T 1999-03-03 2000-02-23 Heterosiklik bileşimler, ara ürünleri ve elastaz inhibitörleri. TR200102540T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11056052A JP2000256396A (ja) 1999-03-03 1999-03-03 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤

Publications (1)

Publication Number Publication Date
TR200102540T2 true TR200102540T2 (tr) 2002-01-21

Family

ID=13016323

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02540T TR200102540T2 (tr) 1999-03-03 2000-02-23 Heterosiklik bileşimler, ara ürünleri ve elastaz inhibitörleri.

Country Status (23)

Country Link
US (1) US6835714B1 (enExample)
EP (1) EP1157998B1 (enExample)
JP (1) JP2000256396A (enExample)
KR (1) KR100622709B1 (enExample)
CN (1) CN1183156C (enExample)
AT (1) ATE259376T1 (enExample)
AU (1) AU758739B2 (enExample)
CA (1) CA2362911A1 (enExample)
DE (1) DE60008218T2 (enExample)
DK (1) DK1157998T3 (enExample)
ES (1) ES2215608T3 (enExample)
HK (1) HK1044955B (enExample)
HU (1) HUP0200608A3 (enExample)
IL (2) IL144813A0 (enExample)
MX (1) MXPA01008836A (enExample)
NZ (1) NZ513594A (enExample)
PL (1) PL199136B1 (enExample)
PT (1) PT1157998E (enExample)
RU (1) RU2222539C2 (enExample)
TR (1) TR200102540T2 (enExample)
TW (1) TW534905B (enExample)
WO (1) WO2000052032A1 (enExample)
ZA (1) ZA200106514B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002546A1 (en) * 2000-06-30 2002-01-10 Seikagaku Corporation EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
KR100939155B1 (ko) * 2000-07-21 2010-01-28 쉐링 코포레이션 C형 간염 바이러스의 ns3-세린 프로테아제 억제제로서의신규한 펩티드
RU2003105221A (ru) 2000-07-21 2004-09-20 Шеринг Корпорейшн (US) Новые пептиды, как ингибиторы ns3-серинпротеазы вируса гепатита с
AR029851A1 (es) 2000-07-21 2003-07-16 Dendreon Corp Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
GB0021315D0 (en) 2000-08-30 2000-10-18 Dainippon Pharmaceutical Co Heterocyclic compounds and intermediates thereof
JPWO2002026229A1 (ja) * 2000-09-29 2004-02-05 小野薬品工業株式会社 気道粘液分泌抑制剤
KR20040081182A (ko) 2002-02-05 2004-09-20 다이닛본 세이야꾸 가부시끼가이샤 엘라스타제-저해 활성을 가진 이종고리 화합물 및 그 중간체
CA2557307A1 (en) * 2004-02-27 2005-09-22 Schering Corporation 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
PT2019837E (pt) * 2006-05-23 2011-07-05 Irm Llc Compostos e composições como inibidores das proteases activadoras de canal
US7951823B2 (en) * 2006-05-23 2011-05-31 Irm Llc Compounds and compositions as channel activating protease inhibitors
WO2008032331A1 (en) * 2006-09-12 2008-03-20 Himalaya Global Holdings Ltd. Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof
AU2008214217B2 (en) * 2007-02-09 2011-10-13 Irm Llc Compounds and compositions as channel activating protease inhibitors
CA2677485A1 (en) * 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
EP2687531B1 (en) 2011-03-18 2016-07-13 ONO Pharmaceutical Co., Ltd. Tetrahydrocarboline derivative
CN104031014B (zh) * 2013-03-08 2016-05-11 华中师范大学 香豆素衍生物及其制备方法以及弹性蛋白酶活性检测方法和检测试剂盒
CN104165869B (zh) * 2013-05-17 2016-12-28 华中师范大学 一种检测蛋白水解酶活性的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS231228B1 (en) 1982-10-01 1984-10-15 Evzen Kasafirek Biologically effective tri and tetrapeptide alkylamide derivatives and their processing method
GB8600263D0 (en) 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
GB8809316D0 (en) 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
KR0143565B1 (ko) 1988-06-13 1998-07-15 사노 가즈오 피발산의 p-치환된 페닐 에스테르 유도체, 그의 제조 방법 및 이를 포함하는 조성물.
IT1245712B (it) * 1991-04-09 1994-10-14 Boehringer Mannheim Italia Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree
IT1255704B (it) * 1992-09-30 1995-11-10 Boehringer Mannheim Italia Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree
US5565568A (en) * 1995-04-06 1996-10-15 Eli Lilly And Company 2-acylaminopropanamides as tachykinin receptor antagonists

Also Published As

Publication number Publication date
IL144813A0 (en) 2002-06-30
EP1157998A4 (en) 2003-01-29
KR100622709B1 (ko) 2006-09-13
CA2362911A1 (en) 2000-09-08
AU758739B2 (en) 2003-03-27
IL144813A (en) 2006-12-10
EP1157998B1 (en) 2004-02-11
ATE259376T1 (de) 2004-02-15
PT1157998E (pt) 2004-06-30
RU2222539C2 (ru) 2004-01-27
MXPA01008836A (es) 2002-05-14
ES2215608T3 (es) 2004-10-16
JP2000256396A (ja) 2000-09-19
DE60008218D1 (de) 2004-03-18
HK1044955B (zh) 2005-07-08
ZA200106514B (en) 2002-05-10
US6835714B1 (en) 2004-12-28
CN1349542A (zh) 2002-05-15
PL199136B1 (pl) 2008-08-29
NZ513594A (en) 2003-04-29
TW534905B (en) 2003-06-01
DK1157998T3 (da) 2004-06-14
KR20020002396A (ko) 2002-01-09
CN1183156C (zh) 2005-01-05
AU2690200A (en) 2000-09-21
HK1044955A1 (en) 2002-11-08
EP1157998A1 (en) 2001-11-28
HUP0200608A3 (en) 2002-09-30
DE60008218T2 (de) 2004-12-09
HUP0200608A2 (en) 2002-08-28
WO2000052032A1 (en) 2000-09-08

Similar Documents

Publication Publication Date Title
TR200102540T2 (tr) Heterosiklik bileşimler, ara ürünleri ve elastaz inhibitörleri.
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
DK1161428T3 (da) Pyrimidinforbindelser
TR200102237T2 (tr) N²-fenil amidin türevleri.
ID29452A (id) 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
TR200200099T2 (tr) Th2 farklılaşma inhibitörleri
DK1042319T3 (da) Dihydrobenzofuraner
NO20026095L (no) Kumarinderivater med COMT inhiberende aktivitet
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
PE20010300A1 (es) Preparacion de piperidin-4-onas sustituidas
TR200200550T2 (tr) Piruvat dehidrojenaz aktivitesini yükselten ikameli n-fenil 2-hidroksi -2- metil -3,3,3- triflüoropropanamid türevleri.
PT1280779E (pt) Novos indanilimidazois policiclicos com actividade adrenergica alfa2
TR200000057T2 (tr) 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları.
ATE408610T1 (de) Alkyl-und piperidin-substitutierte benzimidazol- derivate
MY123639A (en) Substituted isoquinoline derivatives and their use as inticonvulsants
BR0110328A (pt) Compostos heterocìclicos com atividade antiinflamatória
PT1075476E (pt) Novos benzimidazoles e benzoxazoles
TH102375A (th) อนุพันธ์พิแรโซล และการใช้ของมัน